NanoViricides Inc (AMEX:NNVC)’s traded shares stood at 0.3 million during the last session, with the company’s beta value hitting 0.91.The NNVC share’s 52-week high remains $2.77, putting it -83.44% down since that peak but still an impressive 37.75% since price per share fell to its 52-week low of $0.94.

Analysts have given a consensus recommendation of Buy for NanoViricides Inc (NNVC), translating to a mean rating of 1.00. Of 1 analyst(s) looking at the stock, 0 analyst(s) give NNVC a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 1 recommend it as a Buy.

NanoViricides Inc (AMEX:NNVC) trade information

The 5-day price performance for the stock is -1.95%, and 19.84% over 30 days. With these gigs, the year-to-date price performance is 5.59%.

NNVC Dividends

NanoViricides Inc has its next earnings report out in July. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.

The next major institution holding the largest number of shares is BLACKROCK INC. with 0.16 million shares, or about 1.3373% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $0.27 million.

We also have VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund as the top two Mutual Funds with the largest holdings of the NanoViricides Inc (NNVC) shares. Going by data provided on Mar 31, 2025 , VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund holds roughly 352.19 shares. This is just over 2.19% of the total shares, with a market valuation of $0.53 million. Data from the same date shows that the other fund manager holds a little less at 154.51, or 0.96% of the shares, all valued at about 0.23 million.